ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study

M. Park1, Y. Gao1, S. Schroeder2, S. Siyahian1, Z. Laszik1, F. Vincenti1

1UCSF, San Francisco, CA, 2UC Davis, Sacramento, CA

Meeting: 2020 American Transplant Congress

Abstract number: D-033

Keywords: Kidney transplantation, Metabolic complications, Morbidity, Protocol biopsy

Session Information

Session Name: Poster Session D: Kidney: Cardiovascular and Metabolic Complications

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in kidney transplant recipients (KTR). This cohort comprises a prospectively enrolled cohort of KTR with kidney allograft biopsy data, banked biospecimens, and clinical data. Our long-term goal is to use kidney tissue, biomarkers, and images obtained in this cohort along with “real-world” electronic data from the medical record to explore mechanisms of cardiovascular risk in KTR.

*Methods: Between 2014-2017, consecutive KTR undergoing kidney allograft biopsy for cause or protocol at UCSF were enrolled. Detailed data including pathological findings by Banff criteria were systematically abstracted by chart review. For corresponding clinical data, both detailed chart review and querying of the UCSF central data warehouse of the electronic medical record were used. This data warehouse was compiled based on the Observational Methods Outcomes Partnership (OMOP) common data model.

*Results: 422 patients were enrolled and provided biospecimens (serum, plasma, urine). Mean age at the time of consent was 51.2±13.9. 271(57.1%) were men; 116 (27.6%) were white, 64 (15.2%) African American, and 88 (20.9%) Asian. 89 patients had biopsies for cause, 333 for protocol. 403 had cardiovascular disease including hypertension, myocardial infarction, and heart failure at baseline. 26 (6%) had type 1 and 109 (26%) had type 2 diabetes mellitus. Baseline pre-transplant echocardiogram data is available in all participants and repeat research images were obtained in a subset (41).

*Conclusions: The CARAKTER Study will be an important cohort for future investigations into cardiovascular and metabolic complications of kidney transplant. Longitudinal outcomes using the electronic medical record will be ascertained as biospecimen measurements are performed.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Park M, Gao Y, Schroeder S, Siyahian S, Laszik Z, Vincenti F. The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/the-ucsf-cardiovascular-risk-after-kidney-transplantation-carakter-study/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences